Omega-3 Fatty Acids Show Promise for Preventing Age-Related Muscle Loss

Sarcopenia, the progressive loss of muscle mass and strength with aging, affects 10-16% of older adults and significantly increases risks of falls, frailty, and mortality. This condition represents a major public health challenge as populations age globally, making effective interventions critically important for healthy longevity.

This comprehensive review analyzed current evidence on omega-3 polyunsaturated fatty acids (PUFAs) as a nutritional intervention for sarcopenia. Researchers examined multiple clinical trials and mechanistic studies focusing on EPA and DHA supplementation in older adults and clinical populations at risk for muscle wasting.

The analysis revealed that omega-3 supplementation, particularly at doses exceeding 2 grams daily of combined EPA and DHA, can meaningfully improve muscle outcomes. Participants showed increases in thigh muscle volume, handgrip strength, and one-repetition maximum strength. The mechanisms involve enhanced muscle protein synthesis through mTOR pathway activation, reduced inflammation via specialized pro-resolving mediators, and improved mitochondrial function.

Most importantly, benefits were most pronounced when omega-3s were combined with resistance exercise training, with women showing particularly strong responses. The supplements also showed promise in clinical populations including cancer patients with cachexia and individuals with neuromuscular disorders.

However, some large-scale trials like the MAPT study showed null findings for long-term supplementation alone, suggesting omega-3s work best as part of multimodal interventions rather than standalone treatments. The research indicates omega-3 supplementation represents a safe, accessible strategy for maintaining muscle health during aging, though optimal results require combination with exercise training.